Cargando…

Should We Screen HIV-Positive Migrants for Strongyloidiasis?

Background: Strongyloides stercoralis, a nematode endemic in all (sub)tropical regions, can cause life-threatening disease, especially in immunosuppressed patients. Many countries with high HIV-prevalence rates are also highly S. stercoralis endemic, and co-infection may occur. Methods: Retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Theunissen, Caroline, Bottieau, Emmanuel, Van Esbroeck, Marjan, Tsoumanis, Achilleas, Florence, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281463/
https://www.ncbi.nlm.nih.gov/pubmed/32443596
http://dx.doi.org/10.3390/pathogens9050388
_version_ 1783543925980528640
author Theunissen, Caroline
Bottieau, Emmanuel
Van Esbroeck, Marjan
Tsoumanis, Achilleas
Florence, Eric
author_facet Theunissen, Caroline
Bottieau, Emmanuel
Van Esbroeck, Marjan
Tsoumanis, Achilleas
Florence, Eric
author_sort Theunissen, Caroline
collection PubMed
description Background: Strongyloides stercoralis, a nematode endemic in all (sub)tropical regions, can cause life-threatening disease, especially in immunosuppressed patients. Many countries with high HIV-prevalence rates are also highly S. stercoralis endemic, and co-infection may occur. Methods: Retrospective study based on serological testing for S. stercoralis in all HIV-infected migrants followed at the Institute of Tropical Medicine, Antwerp, Belgium. If untested, serologic testing was performed on stored samples, dating from the first HIV viral load determination. The epidemiological, clinical and laboratory features of patients with and without strongyloidiasis were retrieved from the electronic medical files. Results: Of the 2846 HIV patients in active follow-up, 723 (25.4%) had a migration background. Thirty-six patients (5.1%) were diagnosed with Strongyloides co-infection, including 29 during their medical evaluation and seven retrospectively. Patients had a median age of 35.3 years (IQR 30.3–44.4), 28 patients (78%) originated from Sub-Saharan Africa and median time in Belgium was 3.5 years (IQR 0.8–5.7). Symptoms compatible with strongyloidiasis were present in 17 (47%) patients, of whom two were diagnosed retrospectively. Eosinophilia (eosinophil cell count > 450/µL) was observed in 19 (53%) participants. Median CD4 level was 386 /µL (IQR 299–518) at diagnosis of co-infection. Of note, 8 (22%) patients with strongyloidiasis had no reported symptoms nor eosinophilia. None of the patients developed hyperinfection syndrome. There were no differences in age, gender, geographic origin, clinical presentation, CD4 level or viral load between patients with and without strongyloidiasis. Only eosinophilia was strongly correlated with the presence of Strongyloides in multivariate analysis (OR 10.74 (95% CI 5.19–22.25), p < 0.001); the positive likelihood ratio (LR+) of eosinophilia for strongyloidiasis was 5.38 (95% CI 3.66–7.91). Conclusion: Strongyloidiasis was diagnosed in 5.1% of HIV-infected migrants. Eosinophilia had good confirming power for the presence of the disease. However, a sizeable proportion (22%) of co-infected individuals were asymptomatic and had normal eosinophil count, supporting universal screening of all HIV-positive patients native to tropical countries.
format Online
Article
Text
id pubmed-7281463
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72814632020-06-17 Should We Screen HIV-Positive Migrants for Strongyloidiasis? Theunissen, Caroline Bottieau, Emmanuel Van Esbroeck, Marjan Tsoumanis, Achilleas Florence, Eric Pathogens Article Background: Strongyloides stercoralis, a nematode endemic in all (sub)tropical regions, can cause life-threatening disease, especially in immunosuppressed patients. Many countries with high HIV-prevalence rates are also highly S. stercoralis endemic, and co-infection may occur. Methods: Retrospective study based on serological testing for S. stercoralis in all HIV-infected migrants followed at the Institute of Tropical Medicine, Antwerp, Belgium. If untested, serologic testing was performed on stored samples, dating from the first HIV viral load determination. The epidemiological, clinical and laboratory features of patients with and without strongyloidiasis were retrieved from the electronic medical files. Results: Of the 2846 HIV patients in active follow-up, 723 (25.4%) had a migration background. Thirty-six patients (5.1%) were diagnosed with Strongyloides co-infection, including 29 during their medical evaluation and seven retrospectively. Patients had a median age of 35.3 years (IQR 30.3–44.4), 28 patients (78%) originated from Sub-Saharan Africa and median time in Belgium was 3.5 years (IQR 0.8–5.7). Symptoms compatible with strongyloidiasis were present in 17 (47%) patients, of whom two were diagnosed retrospectively. Eosinophilia (eosinophil cell count > 450/µL) was observed in 19 (53%) participants. Median CD4 level was 386 /µL (IQR 299–518) at diagnosis of co-infection. Of note, 8 (22%) patients with strongyloidiasis had no reported symptoms nor eosinophilia. None of the patients developed hyperinfection syndrome. There were no differences in age, gender, geographic origin, clinical presentation, CD4 level or viral load between patients with and without strongyloidiasis. Only eosinophilia was strongly correlated with the presence of Strongyloides in multivariate analysis (OR 10.74 (95% CI 5.19–22.25), p < 0.001); the positive likelihood ratio (LR+) of eosinophilia for strongyloidiasis was 5.38 (95% CI 3.66–7.91). Conclusion: Strongyloidiasis was diagnosed in 5.1% of HIV-infected migrants. Eosinophilia had good confirming power for the presence of the disease. However, a sizeable proportion (22%) of co-infected individuals were asymptomatic and had normal eosinophil count, supporting universal screening of all HIV-positive patients native to tropical countries. MDPI 2020-05-18 /pmc/articles/PMC7281463/ /pubmed/32443596 http://dx.doi.org/10.3390/pathogens9050388 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Theunissen, Caroline
Bottieau, Emmanuel
Van Esbroeck, Marjan
Tsoumanis, Achilleas
Florence, Eric
Should We Screen HIV-Positive Migrants for Strongyloidiasis?
title Should We Screen HIV-Positive Migrants for Strongyloidiasis?
title_full Should We Screen HIV-Positive Migrants for Strongyloidiasis?
title_fullStr Should We Screen HIV-Positive Migrants for Strongyloidiasis?
title_full_unstemmed Should We Screen HIV-Positive Migrants for Strongyloidiasis?
title_short Should We Screen HIV-Positive Migrants for Strongyloidiasis?
title_sort should we screen hiv-positive migrants for strongyloidiasis?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281463/
https://www.ncbi.nlm.nih.gov/pubmed/32443596
http://dx.doi.org/10.3390/pathogens9050388
work_keys_str_mv AT theunissencaroline shouldwescreenhivpositivemigrantsforstrongyloidiasis
AT bottieauemmanuel shouldwescreenhivpositivemigrantsforstrongyloidiasis
AT vanesbroeckmarjan shouldwescreenhivpositivemigrantsforstrongyloidiasis
AT tsoumanisachilleas shouldwescreenhivpositivemigrantsforstrongyloidiasis
AT florenceeric shouldwescreenhivpositivemigrantsforstrongyloidiasis